Nav: Home

Current Hepatitis News and Events

Current Hepatitis News and Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. (2019-06-11)
'Green Revolution' in RNAi tools and therapeutics
A team from Nanjing University in China reported that the small silencing RNA sequences against HBsAg generated in edible lettuce (Lactuca sativa L.) can specifically bind and inhibit gene expression in p21-HBsAg knock-in transgenic mice and improve liver injury at a relatively low level when compared to synthetic siRNAs. (2019-06-10)
Patient groups untested in cancer immunotherapy trials found to also benefit
Cancer patients previously excluded and underrepresented in immunotherapy clinical trials, such as African Americans and patients with HIV or viral hepatitis, actually benefit at the same rate as patients tested in the clinical trials, according to a Georgetown-led study to be presented at the 2019 ASCO Annual Meeting in Chicago. (2019-05-30)
Widespread testing, treatment of Hepatitis C in US prisons improves outcomes
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes. (2019-05-21)
New progress in developing an animal model of hepatitis C
Researchers studying hepatitis C virus have introduced small mutations into mouse liver cells to make the animals more susceptible to the virus, a step toward using mice in hepatitis C vaccine research. (2019-05-10)
Needleless vaccine will protect children from dangerous viruses
Orally administered vaccine can protect millions from hepatitis B. Oral vaccines are both safer and less expensive than injections. (2019-05-03)
Designer drugs to inhibit hepatitis A virus
Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection, according to a study publishing April 30, 2019 in the open-access journal PLOS Biology by Dan Su of Sichuan University, Zihe Rao of Tsinghua University, Xiangxi Wang of the Chinese Academy of Sciences, and colleagues. (2019-04-30)
New research reviews the state of vaccine safety science
A new systematic review provides a succinct summary of the scientific evidence for and/or against causal associations for 47 adverse events following immunization (AEFI). (2019-04-27)
Alcohol relapse rate among liver transplant recipients identical regardless of sobriety period
For decades, patients with liver disease related to alcohol use have been told they must be sober for six months before they can get a liver transplant. (2019-04-25)
Conflicting laws may keep contaminated needles in circulation, add to hep-C cases
A recent study led by Steve Davis, a researcher in the WVU School of Public Health, suggests fear of arrest is a formidable barrier to getting clean needles and disposing of used ones safely. (2019-04-25)
How the hepatitis B virus establishes persistent infection
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao Guo of the Indiana University School of Medicine, Bin Wang and Jiming Zhang of Fudan University, and colleagues. (2019-04-18)
US and Japanese researchers identify how liver cells protect against viral attacks
Researchers in Chapel Hill, N.C., and Tokyo have discovered a mechanism by which liver cells intrinsic resistance to diverse RNA viruses is regulated. (2019-04-15)
Biophotonic therapy eliminates bacteria and viruses from organs before transplantation
Method developed by scientists in Brazil and Canada can prevent transmission of diseases to organ recipients. (2019-04-11)
Glecaprevir/pibrentasvir is effective and well tolerated in individuals with hepatitis C
Two large 'real-world' studies conducted in Germany and the USA have confirmed the high rates of sustained virological response (SVR) observed in controlled clinical studies of glecaprevir/pibrentasvir (G/P) involving individuals with hepatitis C virus (HCV) infection. (2019-04-11)
Discovery of a host mRNA that inhibits immune functions of antiviral protein RIG-I
This study shows that, upon HCV infection, mRNA of selenoprotein P (SeP), a secretory protein produced primarily in the liver, binds to and inhibits the action of RIG-I, an antiviral protein, thus regulating innate immunity. (2019-04-10)
Is maternal vaccination safe during breastfeeding?
In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women. (2019-04-10)
HIV-infected individuals at high risk of NAFLD and progressive liver disease
The increasing burden and risk of non-alcoholic fatty liver disease (NAFLD) associated with HIV infection have today been highlighted in two studies presented at The International Liver Congress™ 2019 in Vienna, Austria. (2019-04-10)
Hepatitis C infections could be prevented by reducing transmission in people who inject drugs
Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43% globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today. (2019-04-09)
Discovery of a restriction factor for hepatitis B virus
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. (2019-04-08)
Experts call for strategies to address public health crisis of opioid, ID epidemics
Citing the spread of infections linked to rising rates of opioid use across the country including HIV, viral hepatitis, skin and soft tissue infections, bone and joint infections and endocarditis, an article published in the Journal of Infectious Diseases calls on the federal government to support coordinated and strengthened responses by infectious diseases and substance use specialists. (2019-04-04)
Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections. (2019-04-03)
Hepatitis C-infected hearts and lungs safely transplanted
In a paper published in the New England Journal of Medicine, the team describes a four-week antiviral treatment regimen started within hours of organ transplantation surgery, preventing establishment of hepatitis C virus (HCV) infection in all patients, and, in so doing, expanding the pool of eligible heart and lung donor organs. (2019-04-03)
Slight decline in hepatitis C diagnoses in Europe
European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. (2019-04-02)
New study identifies genetic variant that could help reduce need for liver transplants
A new study from the Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. (2019-04-02)
WHO guidelines fail to detect half of chronic hepatitis B patients in Ethiopia needing treatment
Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier. (2019-03-28)
Researchers find method to prioritize treatment strategies in hepatitis C in US prisons
There are currently more than three million people in the US with hepatitis C, a condition that can lead to serious and even deadly liver complications. (2019-03-22)
Mayo Clinic researchers identify potential new therapy for liver diseases
Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers. (2019-03-22)
Many recovering from addiction have chronic health problems, diminished quality of life
A study from the Massachusetts General Hospital Recovery Research Institute shows that more than a third of individuals who consider themselves in recovery from an alcohol or other substance use disorder continue to suffer from chronic physical disease. (2019-03-21)
Hepatitis B virus sheds light on ancient human population movements into Australia
Australian researchers have used hepatitis B virus genome sequences to deduce that the mainland Aboriginal population separated from other early humans at least 59,000 years ago. (2019-03-17)
Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B (HBV) or hepatitis C (HCV) experienced poor outcomes. (2019-03-14)
Hepatitis B vaccination in preadolescents lowered the disease incidence rate in Catalonia
Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent according to a study in which the University of Barcelona took part. (2019-03-13)
New hepatitis C cases down by almost 70 percent in HIV-positive men in London
New cases of hepatitis C amongst HIV-positive men in London have fallen by nearly 70 percent in recent years. (2019-03-06)
A silver lining like no other
New technology from the University of South Australia is revolutionizing safe vaccination practices through antibacterial, silver-loaded dissolvable microneedle patches, which not only sterilize the injection site to inhibit the growth of bacteria, but also physically dissolve after administration. (2019-03-05)
Penn team eradicates Hepatitis C in patients after heart transplants from infected donors
Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American Journal of Transplantation. (2019-02-25)
Common virus is 'less prone to mutation' giving hope for vaccine development
One of the commonest causes of congenital disability, the Human Cytomegalovirus (HCMV), is less prone to mutation than previously thought, a finding which could help develop a successful vaccine, UCL researchers have found. (2019-02-25)
Do we have an epidemic? Enhancing disease surveillance using a health information exchange
While disease surveillance has shifted toward greater use of electronically transmitted information to decrease the reporting burden on physicians, the challenge of getting the right information to public health officials at the right time has not been completely solved. (2019-02-11)
The Lancet: Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer, according to a study published in The Lancet. (2019-02-11)
A new protocol for Hepatitis A vaccination to prevent a vaccine-resistant virus
Researchers of the University of Barcelona (UB) have analysed, with massive sequencing techniques for the first time, the evolution of the Hepatitis A virus with samples from patients. (2019-02-08)
OxyContin reformulation to curb opioid abuse led to hepatitis C surge, study finds
Public health officials have blamed the shift from prescription opioids to injectable heroin as a cause of the rise in hepatitis C cases. (2019-02-04)
The Lancet: Major progress against hepatitis C by 2030 is possible, but will need vast improvements in screening, prevention and treatment
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 -- equal to an 80 percent reduction in incidence and a 60 percent reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions globally published in The Lancet. (2019-01-28)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...